Skip to main content

John Young

Equibles does not estimate personal net worth.

Get an email with a short summary when Arvinas, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARVN alerts

About John Young

John Young is recorded as Board Member at Arvinas, Inc. (ARVN) since August 18, 2022. Arvinas, Inc. reported in an 8-K filed June 30, 2025 that John Young resigned as Board of Directors, effective June 30, 2025. Arvinas, Inc. reported in an 8-K filed August 19, 2022 that John Young was appointed Class II director, effective August 18, 2022. Arvinas, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arvinas, Inc. includes Randy Teel, Ph.D. (CEO and Board Member), Briggs Morrison, M.D. (Chairman), Randy Teel (CFO) and 6 others.

“On June 27, 2025, John Young notified Arvinas, Inc. (the "Company") of his decision to resign from the Company's Board of Directors (the "Board") and the Compensation Committee of the Board, effective June 30, 2025.”
Arvinas, Inc. Form 8-K, filed June 30, 2025 · Read the filing
“On August 18, 2022, the Board elected John Young as a director of the Company, effective immediately.”
Arvinas, Inc. Form 8-K, filed August 19, 2022 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2022-08-18–present

Leadership on record at Arvinas, Inc.

Recent activity